Fabrinet ($FN) reported earnings on August 17, 2026. The headline number: quarterly revenue grew 39.3% year over year, a sharp acceleration that puts $FN among the faster-growing names in the technology sector right now.
The stock was priced at $570.91 as of August 14, 2026, giving it a market cap of $18.88B. The trailing P/E stands at 49.0, but the forward P/E drops to 12.8 — a significant gap that reflects the market pricing in a meaningful earnings ramp ahead.
We do not have verified EPS growth figures for this quarter, so we are not publishing a growth percentage. For the latest per-share figures, visit the live $FN page on acceinvestments.com. We also do not have guidance commentary from management at this time.
Recevez le résumé hebdomadaire ACCE
Performance des indices, récapitulatif des sélections, mouvements de score, chaque dimanche. Sans blabla.
What it means
The ACCE score for $FN is 69 out of 100. Breaking that down:
Growth: 100/100 — the 39.3% revenue growth feeds directly into this perfect score.
Momentum: 84/100 — the stock has returned 77.3% over the past year, well ahead of most peers.
Quality: 65/100 — ROE of 20.0% and a net margin of 9.9% are solid for a contract manufacturer. Earnings quality is flagged as strong.
Value: 28/100 — this is the weak spot. At the current price, our 6-model fair value estimate comes in at $142.04, which implies the stock is trading at a substantial premium to that composite estimate. The analyst consensus target sits at $732.44, pointing in the opposite direction. These two figures reflect genuinely different views on what $FN's growth trajectory is worth.
The FCF yield of 1.1% is thin, which is consistent with a stock the market is pricing for continued high growth rather than current cash returns. $FN pays no dividend.
The wide spread between the 6-model fair value and the analyst target is worth noting. Investors who weight quantitative valuation models heavily will see a very different picture than those anchoring to sell-side price targets. Neither view is automatically correct — the 39.3% revenue growth is real, and the question is how long it continues.
For live price, updated score, and full earnings data, see acceinvestments.com/stocks/FN.
See the full picture, free
ACCE scores thousands of stocks across six valuation models, with fair value, conviction and the full thesis on every name. Start free, no card required.